Key result
Out-of-dialysis BP monitoring is recommended over dialysis-unit measurements for managing hypertension in dialysis patients.
Why the study?
Defining appropriate blood pressure targets for dialysis patients remains debated because peridialytic measurements may be confounded and data from large-scale clinical trials are lacking.
This review highlights that out-of-dialysis blood pressure monitoring is superior to dialysis-unit measurements for predicting outcomes in dialysis patients, emphasizing the need for individualized targets and multidisciplinary management.
Supports prioritizing out-of-dialysis BP monitoring; leaves open randomized validation of outcome benefits.
Remarkable progress has recently been achieved in blood pressure (BP) control based on key research findings in the general population. It has been observed that maintaining BP slightly lower than previously recommended goals leads to better clinical outcomes, provided that patients can tolerate it. Previously, BP control targets for dialysis patients were extrapolated from studies conducted on the general population. However, dialysis patients are considered a distinct group with unique characteristics, which makes defining appropriate BP targets a matter of debate. Several observational studies measuring BP in hemodialysis (HD) patients within dialysis units have shown that lower peridialysis BP (pre-, post-, and interdialytic BP) is associated with worse clinical outcomes. However, this association is likely confounded by factors specific to dialysis patients. The relationship between BP and mortality appears to be more linear in patients with fewer underlying cardiovascular diseases and longer survival. Recent studies have indicated that BP measurements taken outside of dialysis sessions, such as standardized BP on nondialysis days, home BP, and ambulatory BP monitoring between HD sessions, are more predictive of clinical outcomes. Due to the varied effects of dialysis-related treatment practices on BP, there is a lack of data from large-scale clinical trials. As a result, it is challenging to provide strong recommendations for BP targets directly applicable to dialysis patients. This review addresses various factors influencing BP in dialysis patients, including the establishment of individualized target BP levels and discussions on maintenance strategies, while incorporating a recent literature review.
No takes yet. Share an insight, caveat, or question.
Ji Yong Jung (2023) conducted a review in Hypertension in dialysis patients. Blood pressure monitoring and control was evaluated. Out-of-dialysis blood pressure measurements, such as home and ambulatory monitoring, are recommended over dialysis-unit measurements for managing hypertension in dialysis patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: